Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

The antibodies target a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Leap Therapeutics, Inc. (NASDAQ:LPTX) released significant updates regarding its recent clinical findings and corporate presentation. In a press release titled “Leap Therapeutics Reports Initial ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

First Check spoke to Dr Priyanka Sehrawat, MD Medicine, DM Neurology (AIIMS Delhi), currently working as senior Neurologist ...

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

Researchers are investigating the link between mindfulness and health, offering potential new options for the treatment and ...